Dr. Ken Anderson is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. Over the last four decades, Dr. Anderson and his world-class research team have spearheaded groundbreaking work that led to the identification and validation of novel drug targets. In turn, they have driven research efforts that translated those targets to therapies that